NCT03042156View on ClinicalTrials.gov

Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy

Active, not recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 10, 2017

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
PalliativeAdvanced CancerImmunotherapyRadiation Therapy
Interventions
RADIATION

Palliative Radiation Therapy

Trial Locations (1)

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03042156 - Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy | Biotech Hunter | Biotech Hunter